3-year-old cancer survivor's has her artwork showcased during PGA Tour's Houston Open (ABC 13 KTRK - March 31, 2024)


Genetic insights could help remove medulloblastoma’s cellular ‘trigger’: Building on a 50-year-old discovery, a team in Texas aims to consign a deadly childhood cancer to the history books (Nature Portfolio - November 13, 2023)

Boy, 9, had double vision. His parents thought he needed glasses. It was a brain tumor (TODAY - May 24, 2023)

Toronto neurosurgeon tapped to lead Texas Children's, Baylor research into childhood brain cancer (Houston Chronicle - February 8, 2023)

Dr. Michael Taylor, a molecular biologist and an international leader in pediatric neuro-oncology, has joined Texas Children’s Hospital and Baylor College of Medicine to become the inaugural director of the institutions’ childhood brain cancer research program. He will focus on pursuing therapies for difficult-to-treat brain tumors.

Learn More

Texas Children's Hospital, Baylor College of Medicine name Dr. Michael Taylor director of research program (Becker's Spine Review - February 9, 2023)

Dr. Michael Taylor joins Texas Children’s Hospital and Baylor College of Medicine as Director of the Pediatric Neuro-Oncology Research Program (Texas Children's Hospital - February 8, 2023)

Houston boy fighting brain cancer gets support from TCU's football team (CBS - January 8, 2023)


ABC 13 Houston: Cypress father whose Olympic dream was cut short helps daughter learn to walk post-cancer (ABC 13 KTRK - October 6, 2022)

Pilot grants awarded to researchers for innovative therapies (September 7, 2022 - Texas Children's Hospital)

EpicentRx and Texas Children’s Cancer Center announce the initiation of a Phase 1 clinical trial with RRx-001 for poediatric CNS tumors (EpicentRx - February 24, 2022)


POT1 gene mutation predisposes to glioma and affects survival in a sex-specific manner (ReNew Houston - April 20, 2021)

Baylor and TCH researchers honored with AACR Team Science Award (Baylor College of Medicine - April 15, 2021)


CAR T cell therapy promising treatment for recurrent pediatric brain cancer (Medical Dialogues - May 3, 2020)

Promising new treatment for recurrent pediatric brain cancer (Baylor College of Medicine - April 27, 2020)


Pediatric Brain Tumor Foundation names awardees of Early Career Development research grants (Pediatric Brain Tumor Foundation - October 17, 2019)

Childhood brain tumor survivors face more struggles (HealthDay Reporter - June 25, 2019)

Pediatric precision medicine approach proven possible in pediatric MATCH trial (OncLive - May 15, 2019)

Pediatric MATCH trial finds more frequent targetable genetic alterations in pediatric cancers than predicted (American Society of Clinical Oncology - May 15, 2019)

Pediatric MATCH study finds more targetable genetic changes than expected (National Cancer Institute - May 15, 2019)

ASCO: Promising start to pediatric MATCH trial (Cancer Network - May 15, 2019)

Dr. Sarah Injac: Emerging research grant – Medulloblastoma (Pediatric Cancer Research Foundation - March 7, 2019) 


Case Beken, 14-year-old with terminal brain tumor, fulfills dream of becoming firefighter (ABC 13 KTRK - August 15, 2018)

Firefighters treat teen with terminal illness as one of their own (KHOU 11 - August 15, 2018)

Sean Gamino, 13, continues fighting through brain tumor (ABC 13 KTRK - July 27, 2018)

St. Baldrick’s Foundation awards seven Baylor faculty with pediatric cancer research grants (Baylor College of Medicine - July 19, 2018)

Claire's story: Braver, stronger than ever (Texas Children's Hospital - April 13, 2018)

First Mutton Bustin' champ of 2018 RodeoHouston is cancer survivor (ABC13 - March 1, 2018)

Researchers develop approach for identifying tumor targets when genetic drivers are unknown (Medical Xpress / Baylor College of Medicine - January 5, 2018)


Clinical trial results show benefit of brain cancer therapy (Baylor College of Medicine - April 20, 2017)

Ranked #6 in Cancer

Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for seven consecutive years.